
Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc.(DRUG)股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
drug · 股价预测 · 4 位分析师(近3月)· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 4 位华尔街分析师
Buy
4 位分析师
共识
评级分布
12 个月目标价
High
$220
Consensus
$160
+144.3% upside
Low
$126
Median: $146 · Last Close: $65.28
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$159.50
144.3% upside
High Target
$220
237.0%
Low Target
$126
93.0%
Current Price
$65.28
as of today
Based on analyst price targets, the DRUG stock price prediction for the next 12 months ranges from $126 to $220. The consensus DRUG price forecast of $159.50 implies 144.3% upside from the current price of $65.28.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $62.02 | ↓ 5.00% |
1-day model range: $61.56–$62.47. Peak: $62.47 (-5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $62 | -4.6% |
| 2028 | $61 | -7.0% |
| 2029 | $60 | -8.3% |
| 2030 | $59 | -9.0% |
| 2031 | — | -9.4% |
基于技术分析的股价预测
14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · DRUG · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-20 | Piper Sandler | Maintains | Overweight→Overweight |
| 2026-03-30 | BTIG | Maintains | Buy→Buy |
| 2026-03-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-17 | BTIG | Maintains | Buy→Buy |
| 2026-01-07 | BTIG | Maintains | Buy→Buy |
| 2026-01-06 | BTIG | Maintains | Buy→Buy |
| 2026-01-02 | Chardan Capital | Maintains | Buy→Buy |
| 2025-12-30 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-09-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Bright Minds Biosciences Inc. (DRUG) stock. Of the recent 13 rating actions, 0 were upgrades and 0 were downgrades. 4 analysts currently cover DRUG.
分析师推荐趋势
DRUG analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测:EPS 与营收一致预期
Revenue This Year
$0M
Revenue Next Year
$34M
EPS This Year
$-6.52
EPS Next Year
$-12.84
↑ 97.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast DRUG EPS of $-6.52 for the current fiscal year, based on estimates from 5 analysts. The DRUG revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
DRUG 股价预测由两类独立数据源支撑:来自 4 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。DRUG 的共识目标价为 $159.50(+144.3% 上行空间),分析师共识为 Buy。
DRUG 的短期预测(明日)为 $62.02(-5.00%)。 DRUG 对 2027 年的股价预测均值为 $62。 DRUG 对 2030 年的预测区间为 $55–$64。
Bright Minds Biosciences Inc. 在 NASDAQ 上市,代码 DRUG。DRUG 在 2027 年的整体展望偏积极,在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
DRUG 预测 · 8 个问题根据 4 位华尔街分析师,DRUG 的 12 个月平均目标价为 $159.50,最高 $220.00、最低 $126.00。若有图表,中位目标价可在上方查看。相对当前价 $65.28,隐含约 +144.3% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.